P699: REAL‐LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME‐POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5‐YEAR‐DATA FROM A BELGIAN REGISTRY.
Autor: | Devos, T., Havelange, V., Theunissen, K., Meers, S., Benghiat, F. S., Gadisseur, A., Vanstraelen, G., Vellemans, H., Bailly, B., Granacher, N., Lewalle, P., De Becker, A., Van Eygen, K., Lejeune, M., Janssen, M., Triffet, A., Vrelust, I., Deeren, D., Mazure, D., Beck, M. |
---|---|
Zdroj: | HemaSphere; 2022 Supplement 3, Vol. 6, p594-595, 2p |
Databáze: | Complementary Index |
Externí odkaz: |